Open access · CC-BY
via OpenAlex
Senolytics attenuates influenza- induced muscular decline in aged mice
Nagaraju Marka, Andreia N. Cadar, Zena L. Haddad, Anchala Anil Rao, Rakshit Raj Bisoi, Erica C. Lorenzo, Laura Haynes, Jenna M. Bartley
Innovation in Aging · 2025 · ▲ 1 citations
Abstract
Abstract Influenza (flu) remains a major burden for older populations with increased morbidity and mortality. In older people, flu infection can lead to loss of physical function. In preclinical murine studies, the Bartley lab previously determined that flu leads to functional decline, muscle-localized inflammation, and muscle degradation and atrophy; and that these effects are exaggerated and prolonged with aging. Cellular senescence(definition) accumulate with aging and leads to excessive inflammation via the senescent-associated secretory phenotype (SASP). Treatment with senolytics(definition), dasatinib and quercetin (D+Q), eliminates senescent cells and improves the health span, metabolic functions, reduces muscle inflammation and promotes satellite cell proliferation in aging animal models. Hence, we aimed to determine if pretreatment with D+Q could protect against flu-induced muscle declines in aging. Aged (18-20M) C57BL6/J male and female mice were treated with D+Q prior to sublethal flu infection. Immune responses, physical function, and skeletal muscle parameters were assessed prior to and following flu challenge. D+Q did not impact flu-induced weight loss, lung viral load, and flu-specific CD4 and CD8 T cells responses in the mediastinal lymph node and spleen. However, D+Q treatment mitigated flu-induced functional declines in both male and female with increased grip strength compared to vehicle control. In male D+Q treatment led to reduced gene expression of muscle atrophy markers Atrogin-1 and MuRF-1 compared to vehicle treated mice at 11- days post-infection. In totality, our results suggest senolytics may protect against flu-induced muscular declines without impacting immune responses in aged mice, which may offer insights for potential therapeutic implications.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/geroni/igaf122.3652
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Marka, N., Cadar, A.N., Haddad, Z.L., Rao, A.A., Bisoi, R.R., Lorenzo, E.C., Haynes, L., & Bartley, J.M. (2025). Senolytics attenuates influenza- induced muscular decline in aged mice. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igaf122.3652
Vancouver
Marka N, Cadar AN, Haddad ZL, Rao AA, Bisoi RR, Lorenzo EC, et al. Senolytics attenuates influenza- induced muscular decline in aged mice. Innovation in Aging. 2025. doi:10.1093/geroni/igaf122.3652.
BibTeX
@article{nagaraju2025Senoly,
title = {Senolytics attenuates influenza- induced muscular decline in aged mice},
author = {Nagaraju Marka and Andreia N. Cadar and Zena L. Haddad and Anchala Anil Rao and Rakshit Raj Bisoi and Erica C. Lorenzo and Laura Haynes and Jenna M. Bartley},
journal = {Innovation in Aging},
year = {2025},
doi = {10.1093/geroni/igaf122.3652},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Innovation in aging 2025
Open access · OA
Senolytics attenuates influenza- induced muscular decline in aged mice
Figshare 2026
Preprint · CC-BY
Caloric restriction reprograms skeletal muscle molecular pathways in non-human primates: potential relevance to human aging biology
Skeletal Muscle 2026
Open access · CC-BY
Caloric restriction reprograms skeletal muscle molecular pathways in non-human primates: potential relevance to human aging biology
Skeletal muscle 2026
Open access · OA
Caloric restriction reprograms skeletal muscle molecular pathways in non-human primates: potential relevance to human aging biology.
Frontiers in Aging 2026
Open access · CC-BY
The effect of metformin treatment during primary influenza infection on heterologous challenge in young and aged mice
Frontiers in aging 2026
Open access · OA